| __timestamp | ADMA Biologics, Inc. | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 347523000 |
| Thursday, January 1, 2015 | 7015946 | 479514000 |
| Friday, January 1, 2016 | 7688238 | 581861000 |
| Sunday, January 1, 2017 | 6229587 | 1326361000 |
| Monday, January 1, 2018 | 3926120 | 1197957000 |
| Tuesday, January 1, 2019 | 2343848 | 1154111000 |
| Wednesday, January 1, 2020 | 5907013 | 2215942000 |
| Friday, January 1, 2021 | 3646060 | 1458179000 |
| Saturday, January 1, 2022 | 3613764 | 1585936000 |
| Sunday, January 1, 2023 | 3300000 | 1627594000 |
| Monday, January 1, 2024 | 2606848000 |
Infusing magic into the data realm
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Incyte Corporation and ADMA Biologics, Inc. have demonstrated contrasting approaches to R&D investment.
Incyte Corporation, a leader in the field, has consistently increased its R&D expenses, peaking at approximately $1.63 billion in 2023. This represents a staggering 368% increase from 2014, underscoring its aggressive pursuit of new therapies. In contrast, ADMA Biologics, Inc. has maintained a more modest R&D budget, with a peak of $9.5 million in 2014, followed by a gradual decline to $3.3 million in 2023.
These trends highlight the diverse strategies within the biotech sector, where some companies prioritize expansive R&D to drive growth, while others adopt a more conservative approach.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: BeiGene, Ltd. vs ADMA Biologics, Inc.
Incyte Corporation vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Incyte Corporation vs Mesoblast Limited: Strategic Focus on R&D Spending
Comparing Innovation Spending: Incyte Corporation and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or ADMA Biologics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Blueprint Medicines Corporation vs ADMA Biologics, Inc.
Pharming Group N.V. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
ADMA Biologics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
ADMA Biologics, Inc. vs MorphoSys AG: Strategic Focus on R&D Spending
ADMA Biologics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending